Publication | Closed Access
Effect of cordycepin (3'-deoxyadenosine) on hematogenic lung metastatic model mice.
66
Citations
13
References
2005
Year
OncologyMedicinePulmonary PharmacologyBronchial NeoplasmTumor InjectionMouse Melanoma CellsAnti-cancer AgentB16-bl6 Melanoma CellsCancer TreatmentReactive Oxygen SpeciePharmacologyCell BiologyTumor MicroenvironmentLung CancerTumor BiologyCancer Growth
We investigated the anti-metastatic effect of cordycepin (3'-deoxyadenosine) on a hematogenic metastatic mouse model which was intravenously injected with B16-BL6 melanoma cells. A 3-hour exposure to various concentrations of cordycepin (0.3, 1 and 3 microg/ml) dose-dependently reduced the number of nodules formed in lung at 15 days after the tumor injection. To elucidate the mechanism of this anti-metastatic effect, we examined the effect of cordycepin on the invasiveness of B16-BL6 cells using a chemo-invasion chamber in vitro. The B16-BL6 cells pretreated with cordycepin (3 microg/ml) for 3 hours showed a significant decrease in invasiveness. Under the same conditions, however, cordycepin did not influence the growth curve of B16-BL6 cells at concentrations up to 3 microg/ml. These results suggest that cordycepin exerts an anti-metastatic action, in part, by inhibiting the invasiveness of mouse melanoma cells.
| Year | Citations | |
|---|---|---|
Page 1
Page 1